메뉴 건너뛰기




Volumn 21, Issue 1, 2011, Pages 86-91

Genetic alterations in the K-Ras gene influence the prognosis in patients with cervical cancer treated by radiotherapy

Author keywords

Cervical cancer; K Ras; Mutation analysis; Prognostic factors

Indexed keywords

GENOMIC DNA;

EID: 79951491860     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182049924     Document Type: Article
Times cited : (27)

References (25)
  • 4
    • 0033695944 scopus 로고    scopus 로고
    • The significance of tumor size in clinical stage IB cervical cancer: Can a cut-off figure be determined?
    • Nakanishi T, Ishikawa H, Nawa A, et al. The significance of tumor size in clinical stage IB cervical cancer: can a cut-off figure be determined? Int J Gynecol Cancer. 2000;10:397-401.
    • (2000) Int J Gynecol Cancer , vol.10 , pp. 397-401
    • Nakanishi, T.1    Ishikawa, H.2    Nawa, A.3
  • 5
    • 0024450296 scopus 로고
    • Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix
    • DOI 10.1016/0090-8258(89)90029-2
    • Alvarez RD, Soong SJ, Kinney WK, et al. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix. Gynecol Oncol. 1989;35:130-135. (Pubitemid 19268543)
    • (1989) Gynecologic Oncology , vol.35 , Issue.2 , pp. 130-135
    • Alvarez, R.D.1    Soong, S.-J.2    Kinney, W.K.3    Reid, G.C.4    Schray, M.F.5    Podratz, K.C.6    Morley, G.W.7    Shingleton, H.M.8
  • 7
    • 0018578536 scopus 로고
    • Classification and grading of invasive squamous cell carcinoma of the uterine cervix
    • Stendahl U, Willen H, Willen R. Classification and grading of invasive squamous cell carcinoma of the uterine cervix. Acta Radiol Oncol Radiat Phys Biol. 1979;18:481-496.
    • (1979) Acta Radiol Oncol Radiat Phys Biol , vol.18 , pp. 481-496
    • Stendahl, U.1    Willen, H.2    Willen, R.3
  • 8
    • 0032770596 scopus 로고    scopus 로고
    • Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma
    • DOI 10.1006/gyno.1999.5420
    • Kristensen GB, Abeler VM, Risberg B, et al. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma. Gynecol Oncol. 1999;74:245-251. (Pubitemid 29377220)
    • (1999) Gynecologic Oncology , vol.74 , Issue.2 , pp. 245-251
    • Kristensen, G.B.1    Abeler, V.M.2    Risberg, B.3    Trope, C.4    Bryne, M.5
  • 9
    • 0024376173 scopus 로고
    • Ras Oncogenes in human cancer: A review
    • Bos JL. Ras oncogenes in human cancer: a review. Cancer Res. 1989;49:4682-4689. (Pubitemid 19213607)
    • (1989) Cancer Research , vol.49 , Issue.17 , pp. 4682-4689
    • Bos, J.L.1
  • 10
    • 0029127661 scopus 로고
    • Frequent ras gene mutations in squamous cell cervical cancer
    • Wong YF, Chung TKH, Cheung TH, et al. Frequent ras gene mutations in squamous cell cervical cancer. Cancer Lett. 1995;95:29-32.
    • (1995) Cancer Lett , vol.95 , pp. 29-32
    • Wong, Y.F.1    Chung, T.K.H.2    Cheung, T.H.3
  • 11
    • 0032878882 scopus 로고    scopus 로고
    • Differences in K-ras codon 12 mutation frequency between 'high-risk' and 'low-risk' HPV-infected samples
    • DOI 10.1006/gyno.1999.5528
    • Golijow CD, Mourón SA, Gómez MA, et al. Differences in K-ras codon 12 mutation frequency between "high-risk" and "low-risk" HPV-infected samples. Gynecol Oncol. 1999;75:108-112. (Pubitemid 29477811)
    • (1999) Gynecologic Oncology , vol.75 , Issue.1 , pp. 108-112
    • Golijow, C.D.1    Mouron, S.A.2    Gomez, M.A.3    Dulout, F.N.4
  • 13
    • 0034837831 scopus 로고    scopus 로고
    • 'Low-risk' and 'high-risk' HPV-infection and K-ras gene point mutations in human cervical cancer: A study of 31 cases
    • Stenzel A, Semczuk A, Rózycska K, et al. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases. Pathol Res Pract. 2001;197:597-603. (Pubitemid 32834399)
    • (2001) Pathology Research and Practice , vol.197 , Issue.9 , pp. 597-603
    • Stenzel, A.1    Semczuk, A.2    Roynska, K.3    Jakowicki, J.4    Wojcierowski, J.5
  • 14
    • 0141888073 scopus 로고    scopus 로고
    • Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPV-associated high grade dysplasia and squamous cell cervical carcinoma
    • DOI 10.1016/S0301-2115(03)00205-7
    • Pochylski T, Kwavniewska A. Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPV-associated high grade dysplasia and squamous cell cervical carcinoma. Eur J Obstet Gynecol Reprod Biol. 2003;111:68-73. (Pubitemid 37235950)
    • (2003) European Journal of Obstetrics Gynecology and Reproductive Biology , vol.111 , Issue.1 , pp. 68-73
    • Pochylski, T.1    Kwasniewska, A.2
  • 19
    • 67651241726 scopus 로고    scopus 로고
    • Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas
    • Woo T, Okudela K, Yazawa T, et al. Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas. Lung Cancer. 2009;65:355-362.
    • (2009) Lung Cancer , vol.65 , pp. 355-362
    • Woo, T.1    Okudela, K.2    Yazawa, T.3
  • 20
    • 61449154484 scopus 로고    scopus 로고
    • KRAS mutation and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: Practical application of patient selection
    • Jimeno A, Messersmith WA, Hirsch FR, et al. KRAS mutation and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: Practical application of patient selection. J Clin Oncol. 2009;27:1130-1136.
    • (2009) J Clin Oncol , vol.27 , pp. 1130-1136
    • Jimeno, A.1    Messersmith, W.A.2    Hirsch, F.R.3
  • 21
    • 68749119351 scopus 로고    scopus 로고
    • KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
    • Loupakis F, Ruzzo A, Cremolini C, et al. KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer. Br J Cancer. 2009;101:715-721.
    • (2009) Br J Cancer , vol.101 , pp. 715-721
    • Loupakis, F.1    Ruzzo, A.2    Cremolini, C.3
  • 23
    • 54949085398 scopus 로고    scopus 로고
    • K-ras mutations and benefit from Cetuximab in advanced colorectal cancer
    • Karapetis CS, Khambata-Ford S, Jonker DJ, et al. K-ras mutations and benefit from Cetuximab in advanced colorectal cancer. N Engl J Med. 2009;359:1757-1765.
    • (2009) N Engl J Med , vol.359 , pp. 1757-1765
    • Karapetis, C.S.1    Khambata-Ford, S.2    Jonker, D.J.3
  • 25
    • 0029147166 scopus 로고
    • Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets
    • Moodie SA, Paris M, Villafranca E, et al. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets. Oncogene. 1995;11:447-454.
    • (1995) Oncogene , vol.11 , pp. 447-454
    • Moodie, S.A.1    Paris, M.2    Villafranca, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.